A pilot study in rhesus macaques to assess the treatment efficacy of a small molecular weight catalytic metalloporphyrin antioxidant (AEOL 10150) in mitigating radiation-induced lung damage

Health Physics

Volumn 106, Issue 1, 2014, Pages 73-83

  Garofalo, Michael C ^a   Ward, Amanda A ^a   Farese, Ann M ^a   Bennett, Alexander ^a   Taylor Howell, Cheryl ^a   Cui, Wanchang ^a   Gibbs, Allison ^a   Prado, Karl L ^a   Macvittie, Thomas J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

computed tomography; health effects; human; laboratory animals; lungs

Indexed keywords

AEOL 10150; ANTIOXIDANT; DEXAMETHASONE; METALLOPORPHYRIN; OXYGEN; RADIOPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; BLOOD; BREATHING; CATALYSIS; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; LUNG; MALE; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PNEUMONIA; RHESUS MONKEY; SURVIVAL RATE;

ANIMALS; ANTIOXIDANTS; CATALYSIS; DEXAMETHASONE; LUNG; MACACA MULATTA; MALE; METALLOPORPHYRINS; MOLECULAR WEIGHT; OXYGEN; PILOT PROJECTS; RADIATION INJURIES, EXPERIMENTAL; RADIATION PNEUMONITIS; RADIATION-PROTECTIVE AGENTS; RESPIRATION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84889570788     PISSN: 00179078     EISSN: 15385159     Source Type: Journal    
DOI: 10.1097/HP.0b013e3182a4d967     Document Type: Article

References (34)

1. Anscher MS, Murase T, Prescott DM, Marks LB, Reisenbichler H, Bentel GC, Spencer D, Sherouse G, Jirtle RL. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 30: 671-676; 1994.
2. Anscher MS, Marks LB, Shafman TD, Clough R, Huang H, Tisch A, Munley M, Herndon JE, Garst J, Crawford J, Jirtle RL. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19: 3758-3765; 2001.
3. Baumann M, Appold S, Geyer P, Knorr A, Voigtmann L, Herrmann T. Lack of effect of small high-dose volumes on the dose-response relationship for development of fibrosis in distant parts of the ipsilateral lung in mini-pigs. Int J Radiat Biol 76: 477-485; 2000.
4. Berkely FJ. Managing the adverse effects of radiation therapy. AM Fam Physician 82: 381-388; 2010.
5. Crawford LM. New drug and biological drug products; Evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Federal Register 67: 37988-37998; 2002. 21 CFR parts 314 and 601, FDA, HHS
6. Down JD. The expression of early and late damage after thoracic irradiation: A comparison between CBA and C57B1 mice. Radiat Res 96: 603-610; 1983.
7. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 35: 236-256; 2003.
8. FDA. Guidance for industry. Animal modelsVessential elements to address efficacy under the animal rule. 21 CFR Part 314.600 for drugs; 21 CFR 601.90 for biological products. Washington, DC: U.S. Government Printing Office; 2009.
9. Fleckenstein K, Zgonjanin L, Chen L, Rabbani Z, Jackson IL, Thrasher B, Kirkpatrick J, Foster WM, Vujaskovic Z. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. International J Radiat Oncol Biol Phys 68: 196-204; 2007.
10. Franko AJ. The genetic basis of strain-dependent differences in the early phase of radiation injury in mouse lung. Radiat Res 126: 349-356; 2010.
11. Fridovich I. Superoxide dismutases. Ann Rev Biochem 44: 147-159; 1975.
12. Fryer CJH, Fitzpatrick PJ, Rider WD, Poon P. Radiation pneumonitis: Experience following a large single dose of radiation. Int J Radiat Oncol 4: 931-936; 1978.
13. Gauter-Fleckenstein BG, Fleckenstein K, Owzar K, Jiang C, Reboucas JS, Batiric-Haberle I, Vujaskovic Z. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage. Free Radic Biol Med 48: 1034-1043; 2010.
14. Ghobaldi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P. Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 76: 548-556; 2010.
15. Gross NJ, Narine KR, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res 113: 112-119; 1988.
16. Gross NJ. Radiation pneumonitis in mice. Some effects of corticosteroids on morality and pulmonary physiology. J Clin Invest 66: 504-510; 1980.
17. Herrmann T, Baumann M, Voigtmann L, Knorr A. Effect of irradiated volume on lung damage in pigs. Radiother Oncol 44: 35-40; 1997.
18. Hill RP. Radiation effects on the respiratory system. Brit J Radiol 27: 81; 2005.
19. Liao ZX, Travis EL, Tucker SL. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys 32: 1359-1370; 1995.
20. MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, Shea-Donohue T, Gelfond D, Mcfarland E, Jackson IW, Lu W, Farese AM. The prolonged gastrointestinal syndrome in rhesus macaques: The relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation. Health Phys 103: 427-453; 2012a.
21. MacVittie TJ, FareseAM,Bennett A, GelfondD, Shea-DonohueT, Tudor G, Booth C, Mcfarland E, Jackson W III. The acute gastrointestinal subsyndrome of the acute radiation syndrome: A rhesus macaque model. Health Phys 103: 411-426; 2012b.
22. Mah K, Van Dyk J. Quantitative measurement of changes in human lung density following irradiation. Radiotherapy Oncol 11: 169-179; 1988.
23. Marks LB, Yu X, Vujaskovic Z, SmallWJr, Folz R, Anscher MS. Radiation-induced lung injury. Semin Radiat Oncol 13: 333-345; 2003.
24. Muggenburg BA, Hahn FF, Menache MG, Guilmette RA, Boecker BB. Comparative deterministic effects of inhaled, insoluble alpha- and beta-particle-emitting radionuclides in dogs. Radiat Res 152: S23-S26; 1999.
25. Newcomb CH, Van Dyk J, Hill RP. Evaluation of isoeffect formulae for predicting radiation-induced lung damage. Radiother Oncol 26: 51-63; 1993.
26. Noor R, Mittal S, Iqbal J. Superoxide dismutaseVapplications and relevance to human diseases. Med Sci Monitor 8: RA210-RA215; 2002.
27. Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu,Zn-SOD in mitochondria. J Biol Chem 276: 38388-38393; 2001.
28. Phillips TL, Wharam MD, Margolis LW. Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 35: 1678-1684; 1975.
29. Prato FS, Kurdyak R, Saibil EA, Carruthers JS, RiderWD, Aspin N. The incidence of radiation pneumonitis as a result of single fraction upper half body irradiation. Cancer 39: 71-78; 1977.
30. Rabbani ZN, Salahuddin FK, Yarmolenko P, Batinic-Haberle I, Thrasher BA, Gauter-Fleckenstein B, DewhirstMW, Anscher MS, Vujaskovic Z. Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation. Free Radic Res 41: 1273-1282; 2007.
31. Riley PA. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Oncol Biol Phys 65: 27-33; 1994.
32. Taketa ST, Carsten AL, Cohn SH, Atkins HL, Bond VP. Active bone marrow distribution in the monkey. Life Sci 9: 169-174; 1970.
33. Van Dyk J, Keane TJ, Kan S, Rider WD, Fryer CJ. Radiation pneumonitis following large single dose irradiation: A reevaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys 7: 461-467; 1981.
34. Vujaskovic Z, Groen HJ. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 76: 511-516; 2000. Diseases